Latham & Watkins Advises Mission in US$430 Million Acquisition of Calavo Growers

Latham & Watkins LLP advised Mission Produce, Inc. in its US$430 million acquisition of Calavo Growers, Inc. The deal, structured as a cash-and-stock transaction, will result in Calavo stockholders receiving US$27 per share, composed of cash and Mission shares. This acquisition is subject to regulatory and shareholder approvals and is expected to close by the end of August 2026.

Original reporting
Published Jan 15, 2026, 10:58 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jan 15, 2026, 11:00 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Latham & Watkins Advises Mission in US$430 Million Acquisition of Calavo Growers — source image
Decision brief

The 30-second read

$CVGWBullishHigh
01

Why it matters

The deal is expected to enhance competitive positioning but may attract regulatory scrutiny, which could influence stock performance.

02

Market read

Significant for investors in the fresh produce sector, indicating industry consolidation and growth potential.

03

What to watch

Potential integration challenges post-acquisition and market saturation risks.

Timing: Immediate, as the deal is pending regulatory and shareholder approvals.

Background

The acquisition aims to expand Mission Produce's market share and product offerings in the fresh produce industry.

Company-level read

Ticker impact

$CVGWBullishHigh confidence
Context

High relevance due to recent acquisition activity involving the company.

Expected impact

Moderate upward movement expected in CVGW stock price post-announcement, contingent on regulatory approval.

Evidence & confidence

The acquisition signifies growth prospects and industry consolidation, which are typically positive catalysts for the target company's stock.

Market effects

Potential strengthening of the retail and wholesale food sectors due to consolidation.

Primarily US-focused, with possible ripple effects in North American markets.

Limited, as the transaction is region-specific and industry-specific.

Counterpoint

Regulatory hurdles or antitrust concerns could delay or block the deal, negatively impacting CVGW stock.

Key entities

  • Mission Produce, Inc.

    A global leader in avocado and fresh produce distribution.

  • Calavo Growers, Inc.

    A major player in the avocado and fresh produce industry.

Related articles

$GDMedAI 9/10

General Dynamics wins $249m in US military contracts

General Dynamics (GD) won two U.S. military contracts totaling $248.9M. One is a $149.6M contract for USS Pinckney modernization, with potential value up to $149.9M. The other is a $99.3M task order for MUOS Ground Infrastructure Segment upgrades. Both contracts are sole-source and involve work through 2028, funded by fiscal 2026 budgets.

$LMTHighAI 9/10

Lockheed Martin wins $150 million in defense contracts

Lockheed Martin Corp received three contract modifications worth over $150 million from the U.S. Department of Defense. The largest, $90.2 million, is for the TRIDENT II Life Extension 2 program, with work spread across multiple locations. The other contracts, $40.1 million and $20.3 million, are for the MK 41 Vertical Launching System and HH-60W repairs, respectively. Completion dates range from 2027 to 2030.

$NVSMedAI 8/10

Novartis Pharma AG: Novartis announces Lp(a)HORIZON Phase III topline results for pelacarsen in patients with elevated Lp(a) and established cardiovascular disease (CVD)

Novartis announced that the Phase III Lp(a)HORIZON trial for pelacarsen did not meet its primary endpoint of reducing cardiovascular events. The study, involving 8,323 patients, showed that while pelacarsen lowered Lp(a) levels, it did not reduce cardiovascular risk. Novartis obtained rights to pelacarsen from Ionis Pharmaceuticals. Elevated Lp(a) affects about 20% of people worldwide and has no approved targeted treatment.

$DELLMed

3 AI Stocks to Buy (and 2 to Skip) as the AI Buildout Hits a New Gear

Microsoft, Google, and Dell reported strong earnings and growth. Dell's revenue grew 58% YoY, with AI server backlog at $60.9B. Credo Technology Group saw 115% revenue growth but faced stock decline due to margin concerns. Fervo Energy secured a major geothermal deal with Google. FuelCell Energy and Eos Energy Enterprises also reported updates. The article discusses AI and energy sector trends, highlighting liquidity issues and strong fundamentals.

$MUMed

Analyst Has Strong Take on Micron, SanDisk Stocks

Lynx Research predicts breakouts for Micron (MU) and SanDisk (SNDK), assigning targets of $1,325 and $2,450, implying 31.7% and 41.9% upside. The firm cites reduced volatility and steady buying in the memory sector. Both companies benefit from tightening supplies and AI demand. MU's volatility eased in August, while industry fundamentals remain supportive.